Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3. This reflects a minor version update of the page rather than changes to the study details or substantive content.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page now displays the updated revision tag (v3.6.2) indicating a newer build of the page, rather than a change to study details.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and a recruitment status label 'No longer looking for participants', along with an updated site revision tag 'Revision: v3.6.0'. The removal of the 'Intervention / Treatment' label and the older 'Revision: v3.5.5' entry indicates a UI cleanup and version update.SummaryDifference0.4%

- Check31 days agoChange DetectedThe page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated site build.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3, indicating a software update behind the page. No visible content changes to the study details are indicated.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision was bumped from v3.5.2 to v3.5.3, indicating a new version of the page content has been published. This reflects maintenance or minor behind-the-scenes updates to the page.SummaryDifference0.0%

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.